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 The bioactive compound have to be extracted from the marine sponge Spirastrella inconstans for 
treatment against Methicillin Resistant Staphylococcus aureus (MRSA), which were isolated from the chronic 
wound of fisherman community of east and west coastal villages of India. About 100 MRSA strains were 
isolated from the pus samples and confirmed using standard biochemical tests. Since those strains developed 
resistance to almost all type of antibiotics, alternative bioactive compounds are needed for the treatm nt. 
Spirastrella inconstans was selected in which the crude bioactive compound were extracted by solvent 
extraction method. The antimicrobial activity was performed using agar well cutting and paper disc diffusion 
methods, in which chloroform extract was the most active compared to that of other solvents, with a maxi um 
of 30 mm diameter of zone of inhibition. That crude extract protein was estimated by using Lowry’s method. 
The protein was precipitated using ammonium sulphate precipitation method and purified using dialysis. The 
purified protein was found to be of 3,000 Da molecuar weight by SDS-PAGE, it can be used for the treatm nt 
of wound infection though the structural and molecuar elucidations need to be done in the future. 
© 2012 International Formulae Group. All rights reserved. 
 




Staphylococcus aureus is a major 
pathogen causing large variety of infections 
worldwide and predominates in surgical 
wound infections with prevalence rate ranging 
from 4.6 to 54.4%. It causes superficial skin 
infections and life threatening diseases such as 
endocarditis, sepsis and soft tissue, urinary 
tract, respiratory tract, intestinal tract and 
bloodstream infections (Chakraborty et al., 
2011). 
S. aureus has developed resistance to 
most classes of antimicrobial agents. 
Penicillin was the first choice of antibiotics to 
treat staphylococcal infection. In 1994, by 
destroying the penicillin by penicillinase, S. 
aureus became resistant to penicillin. 
Methicillin, a semi synthetic penicillin was 
used to treat penicillin resistant S. aureus 
infection but resistance finally emerged in 
1962. Following this, Methicillin Resistant 
Staphylococcus aureus (MRSA) emerged 
(Livermore, 2001; Cui et al., 2000).   





Since MRSA was first described in 
1961, it has been regarded as a nosocomial 
pathogen that is not normally present in the 
community. However, this notion has changed 
greatly in the past 15 years, and CA-MRSA 
infections are now prevalent and widespread. 
Although MRSA infections acquired from the 
community were reported in Detroit, MI, 
USA, in 1982, all patients had predisposing 
risk factors for infection, such as previous 
hospital admission or intravenous drug abuse. 
The first genuine cases of CA-MRSA 
infection were reported among individuals 
from Kimberley, Western Australia, in the 
early 1990s (DeLeo et al., 2010). 
Oceans are said to be the medicine 
chest of the future. Sponges and corals offer a 
rich source of unique and diverse natural 
products,most of which have potent 
pharmacological activities (Dovi Kelman et 
al., 2009). Antibiotics isolated from marine 
sponge were active against human pathogens 
or marine bacteria. The rich source of unique 
and diverse secondary metabolites from 
sponge has potent pharmacological activities, 
including anti-tumor, antifungal, anti-viral and 
anti-bacterial properties. The controlled 
diffusion of antibiotic agents in the living 
tissues of sponges may increase the efficiency 
and thereby provide a better defense against 
microbial infections (Dovi Kelman et al., 
2001). Natural products were also found to 
play important biological and ecological roles 
for the producing organisms such as defense 
against predators, competition for space, 
prevention of fouling, roles in reproduction 
and antimicrobial activity. Antimicrobial 
activity has been extensively reported from 
various groups of marine organisms, such as 
sponges, bryozoans, ascidians, scleractinian 
corals, gorgonian octo-corals, and 
alcyonacean soft corals. Several antibiotics 
have been isolated, such as plakortin and 
manoalide from marine sponges (Dovi 
Kelman et al., 2009). 
Despite the wealth of biologically 
active secondary metabolites isolated from 
marine sponges, the potential functions of 
these compounds in antimicrobial chemical 
defense have rarely been explored. The first 
report of antimicrobial activity of sponge 
extracts was done by Nigrelli et al. 
(1959).Since last two decades, research in to 
marine natural products has expanded rapidly. 
The oceans are a source of a large group of 
unique natural products, marine 
microorganisms whose immense genetic and 
biochemical diversity is only beginning, likely 
to become rich source of novel chemical 
entities for the discovery of more effective 
drugs. Among all marine organisms screened, 
marine sponges produce the largest number of 
structurally diverse natural products, and in 
fact represent the single best source of marine 
bioactive compounds, which acts as secondary 
metabolites (Radhika et al., 2007). The marine 
sponges are shown to exhibit anti-bacterial, 
anti-insecticidal, anti-viral, anti-plasmodial 
activities and anti-leishmanial activity 
(Lakshmi et al., 2009). 
The objective of this study was to 
identify the drug from Spirastrella inconstans 
for the treatment of wound caused by MRSA 
among fisherman community. 
 
MATERIALS AND METHODS 
Isolation of MRSA 
MRSA strains were isolated from the 
chronic wound caused due to fishing, or any 
other agents among fisherman community of 
east and west coastal villages of India. They 
were confirmed using standard routine 
biochemical tests (Mohankumar et al., 2012). 
Totally, 100 strains were isolated and their 
antimicrobial activity was evaluated using 
marine sponge, since they developed 





resistance to almost all types of antibiotics 
(Baba et al., 2010). 
 
Isolation of sponge 
The sponge sample was collected from 
Gulf of mannar, Tamilnadu and the specimen 
were stored at -20 °C and transported by 
maintaining the temperature below 0 °C and 
identified as Spirastrella inconstans. The 
aqueous extract of sponge was prepared by 
squeezing the sand free specimens in distilled 
water. The resultant solution was filtered and 
dialyzed by using Sigma dialysis membrane 
500 against D-glucose. The supernatant, the 
crude aqueous extract, was stored at 4 ºC.  
 
Solvent extraction 
10 mg of Spirastrella inconstans tissue 
was shocked with 200 ml of solvents, covered 
and kept standing for 5 hrs. The solvent was 
then removed after squeezing the sponge and 
filtered through Whatman No 1 filter paper 
then evaporated at 45 ºC according to the 
method of Gerald and Green Gerardo (1981). 
Homogenized Spirastrella inconstans 
(20 mg) was taken with different solvents 
such as chloroform, dichloromethane, 
methanol, ethanol, petroleum ether and 
acetone. They were soaked, packed tightly 
and kept in dark condition for three days, 
though the biomolecules present in 
Spirastrella inconstans get mixed with 
solvent. The process was repeated using fresh 
solvent, until it is quite satisfied that the entire 
bioactive compound soluble in solvent has 
been extracted. The supernatant, which is 
yellowish when extracted for the first time, 
indicated the presence of solvent-soluble 
compounds while the supernatant, which is 
crystal clear when extracted for the third time, 
indicated that there are no more solvent-
soluble compounds present in it (Zakaria et 
al., 2004). The solvent was evaporated to form 
layer. One ml of solvent was poured over the 
precipitate and the extract was stored in 
eppendorf for antimicrobial activity tests. 
 
Antimicrobial activity of Spirastrella 
inconstans against MRSA 
Paper disc diffusion method  
A concentration of 500 µg disc-1 of 
Spirastrella inconstans extracts was applied to 
each sterile paper discs (6 mm in diameter). 
The solvent was evaporated before they were 
placed on to agar plates that were previously 
seeded with MRSA. The diameter of the 
inhibition zones was measured in mm after 
incubation at 30 °C for 24 hrs. Solvent control 
discs without extract were prepared in the 
same manner and were never observed to 
inhibit bacterial growth (Thakur et al., 2003). 
Well cutting method 
Compared to Paper disc diffusion 
method, well cutting method showed efficient 
results so later was taken into account. MRSA 
turbidity was matched with Mac Farland 
standard and 100 µl of overnight culture was 
swabbed in Mueller Hinton Agar (MHA) 
plate, allowed it for 2-5 min then the wells 
were made using cork borer. 50 µl of the six 
different extracts were added in the order of 
single extract in center and the remaining 
extract around it, allowed it for 10 min, and 
kept at    4 °C for 30 min. After 24 hrs, the 
zones of diameter of inhibition were reported.  
 
Quantitative estimation of protein by 
Lowry’s method 
Bovine serum albumin was pipetted in 
series of 0 µl (Blank), 5 µl, 10 µl, 20 µl, 30 µl, 
40 µl, 50 µl, 60 µl, 75 µl, 100 µl and 150 µl. 
0.2 ml of water added to blank; other tubes 
were also made to 0.2 ml. Then 1.0 ml of 
Solution D was added, after 10 min 0.3 ml of 
Solution E (Folin’s phenol reagent) added, 
vortexed and incubated for 60 minute at room 





temperature. A blank without protein was 
prepared. OD was measured at 660 nm. By 
standard graph, the amount or presence of 
protein was detected (Lowry et al., 1951). 
 
Ammonium sulphate precipitation method 
for Spirastrella inconstans protein 
5.0 mg body wall was homogenized 3 
times with 100 ml of 50 mM Sodium acetate 
buffer at 4 °C. The homogenate was kept 
overnight at 4 °C. Centrifuged at 10,000 g for 
20 min at     4 °C, then 20-80% saturation of a 
ammonium sulphate fraction of supernatant 
was prepared and precipitated protein was 
dissolved in PBSC (Bei-Wei Zhu et al., 2008). 
 
Ammonium sulfate fractionation 
Ammonium sulfate was added to 
fraction 1 at 20% saturation for 30 min. The 
precipitate was centrifuged at 10,000 rpm for 
30 min (Fraction II) and to the supernatant 
ammonium sulfate was added at 40% 
saturation. Repeating centrifugation (Fraction 
III) was done. The supernatant was similarly 
treated with ammonium sulfate at 60 and 80% 
saturation and fractions IV and V obtained. 
All the precipitates (II-V) were dialyzed 
against the same buffer. All the concentrated 
fractions (II-V) were subjected to protein and 
enzyme activity for maximum activity. 
Enzyme activity is expressed as U/ml and one 
unit (U) of activity is defined as µ mols of free 
fatty acids liberated /min/ml by the enzyme 
solution under assay conditions. Ammonium 
sulfate added to precipitate the protein was 
calculated from the standard chart and 
represented in Table 1. The pellet obtained by 




One dimension SDS-PAGE was carried 
out following modified method of Laemmli, 
1970. SDS-PAGE was run on vertical slab gel 
system. Proteins were electrophorised on 12% 
separating gel (0.75 mm thickness) overlaid 
with 5% stacking gel. A 10 % (w/v) stock 
solution of precipitated protein in deionized 
water was run in SDS-PAGE (Boobathy et al., 
2009). 
 
Purification of protein sample by dialysis 
The dialysis bag was boiled with 
distilled water for half an hour, immersed in 
water for overnight. To the tighed dialysis bag 
1.61 ml/cm sample was loaded, immersed in 
Sodium Phosphate buffer and dialyses were 
carried out for 24 hrs using Magnetic stirrer. 
The buffer solution was checked with 
Nesselers reagent for removal of Ammonia. 
1.0 ml of purified enzyme, collected from 
20%, 40%, 60% and 80% saturation levels 
were used for dialysis, to purify the 
impurities. 








Amount of ammonium 
sulfate added (gm) 
1 Initial 43 - 
2 20 43 4.859 
3 40 43 5.203 
4 60 43 5.590 
5 80 45 6.020 






Isolation of MRSA 
The isolated strains were confirmed as 
Methicillin Resistant Staphylococcus aureus 
(MRSA) by using standard biochemical 
characterization and by observing the positive 
growth in selective media for the growth of 
MRSA. 
 
Antimicrobial activity of Spirastrella 
inconstans against MRSA 
Among six solvents of Spirastrella 
inconstans (chloroform, dichloromethane, 
methanol, ethanol, petroleum ether and 
acetone) extract tested with the isolates 
showing more than 60% resistance to 
antibiotics, chloroform seems to be much 
effective and petroleum ether extract does not 
shows any activity. Optimum level of action 
was observed in case of other solvents extracts 
such as dichloromethane, methanol, ethanol 
and acetone. The strainsFM 4, FM 72, FM 84 
and FM 88 showed maximum inhibition with 
chloroform extract, among which 30 mm 
diameter of zone of inhibition was observed 
with strain FM 72. MRSA strain FM 68 
showed maximum inhibition with methanol 
extract of Spirastrella inconstans, the strain  
FM 22 showed maximum inhibition with 
ethanol extract compared to other MRSA 
strains (Table 2). 
 
SDS-PAGE 
The precipitates collected at 40% and 
60% saturation levels were shown to content 
protein, which were quantified by Lowry’s 
method and analyzed by SDS-PAGE. The 
bands obtained were compared with the low 
molecular weight marker, and revealed that 
the Spirastrella inconstans protein extract 
contains a 3,000 Da protein (Figure 1). Thus 
this study shows that this protein of 





“1, 2”:  Protein precipitates by ammounium sulphate pr cipitation method;   
“M”:  Low molecular weight marker. 
 
Figure 1: Separation of crude protein in Spirastrella inconstans by SDS-PAGE. 
  





Table 2: Antimicrobial activity of Spirastrella inconstans protein extracts  against MRSA. 
 
Diameter of Zone of Inhibition (mm) of Spirastrella inconstans protein extracts 




Methanol Ethanol Petroleum 
Ether 
Acetone 
1 FM 4 24 16 16 16 10 - 
2 FM 5 11 - - 11 - - 
3 FM 6 10 11 - - - 11 
4 FM 20 14 12 14 18 16 - 
5 FM 21 10 - 8 10 - - 
6 FM 22 12 12 15 22 - - 
7 FM 23 11 11 10 16 - - 
8 FM 26 14 12 12 - - - 
9 FM 27 10 - 11 8 - - 
10 FM 31 12 10 10 12 - - 
11 FM 32 12 11 16 10 15 - 
12 FM 45 14 11 8 9 - - 
13 FM 47 14 9 13 11 - - 
14 FM 48 12 13 12 13 - - 
15 FM 49 20 18 14 18 15 - 
16 FM 50 14 9 19 18 - - 
17 FM 51 14 14 10 11 - - 
18 FM 53 18 16 11 11 - - 
19 FM 54 14 10 11 10 - - 
20 FM 55 14 12 12 - - - 
21 FM 56 13 - - 11 - - 
22 FM 58 17 - - 13 - - 
23 FM 60 14 18 10 11 - - 
24 FM 61 15 11 - 11 - - 
25 FM 62 15 10 14 11 - - 
26 FM 68 12 11 20 10 - - 
27 FM 69 15 10 10 17 - - 
28 FM 70 16 12 11 12 - - 
29 FM 71 15 15 10 - - - 
30 FM 72 30 14 - 16 - - 
31 FM 73 12 - 11 13 - 11 
32 FM 74 15 - 10 15 16 11 
33 FM 76 13 14 10 15 - - 
34 FM 80 14 12 12 13 - - 
35 FM 81 10 - 16 15 - - 
36 FM 82 12 11 16 14 10 11 
37 FM 83 15 11 10 15 10 12 
38 FM 84 24 13 16 17 - 17 
39 FM 85 17 - - 15 - - 
40 FM 86 12 - 13 18 - - 
41 FM 88 23 8 15 18 11 14 
42 FM 92 14 16 - 12 - - 
43 FM 93 11 - - 13 - - 
44 FM 95 9 - - - - - 
“FM”: Fisherman wound MRSA strain;      —:  Absence of zone of inhibition. 
 






Antibacterial activity of the crude 
Spirastrella inconstans protein extract showed 
zones of inhibition in the range of 8-30 mm 
against S. aureus. But in antibacterial activity 
of the crude induced hemolymph of Scylla 
serrata against S. aureus by disc diffusion 
technique was determined as 11 mm. The 
antibacterial activity of the nitrogen 
heterocyclic sponge constituent cribrostatin 6 
was examined, which was bacteriostatic for a 
variety of gram-positive species. Infections 
caused by antibiotic-resistant gram-positive 
bacteria are a major cause of morbidity and 
mortality. Resistance includes Vancomycin 
resistance in enterococci, Penicillin resistance 
in streptococci and Methicillin resistance in 
staphylococci according to Pettit et al. (2004). 
All the protein fractions were subjected 
to antimicrobial sensitivity testing against 
those MRSA that were sensitive to the crude 
Spirastrella inconstans protein previously. 
The fractions F4 and F79 were found to show 
activity against MRSA that have already 
shown sensitivity to the crude protein, 
whereas other fractions, apart from the above 
two i.e, F1 to F300 did not show any activity 
in our report. All the protein fractions were 
subjected to antimicrobial sensitivity testing 
against those bacteria that have activity to the 
crude induced hemolymph. The fractions F1 
to F9 were found to show an activity against 
them, whereas other fractions (F10 to F17) did 
not show any activity (Hoq et al., 2003) (this 
reference seems not at the correct position, no 
need to cite references for a work done by the 
author himself!). 
The antibacterial activity of our sponge 
protein Glutamic acid was against gram 
positive bacteria Staphylococcus aureus. But 
Schroder et al. (2003) suggested that the 
antibacterial activity of sponge protein 
LEC_SUBDO was against the Gram-negative 
bacteria E. coli and the Gram-positive bacteria 
S. aureus. The lectin was added to the bacteria 
and incubated. The antibacterial activity was 
determined in colony-forming units and 
expressed in percent inhibition. The Inhibitory 
effect of the lectin on the Gram-positive 
bacteria S. aureus was comparatively low. At 
a concentration of 300 µg/ml natural lectin, an 
inhibition of only 15% was appeared; for the 
recombinant protein, the activity rather lower 
of 8%, remains as the contrast report in this 
study. 
MRSA of our study develops multidrug 
resistance against other marine organism due 
to its thick wall and negative charge. The 
ability of Staphylococcus aureus to adhere to 
the extracellular matrix and plasma proteins 
deposited on biomaterials is the significant 
factor in the pathogenesis. Rajagopal et al. 
(2008), reported that Clathria sp. showed 
more antimicrobial activity than the other 
sponges against Staphylococcus sp. Dovi 
Kelman et al. (2009) reported the eight out of 
eleven (73%) of the sponge species which 
inhibited at least one bacterial isolate. Among 
them, Amphimedon chloros exhibited the 
highest antimicrobial activity. A. chloros 
associated bacteria, resistant to them as well 
as to polymixin B, lead us to suggest that the 
amphitoxins and halitoxins mimic the mode of 
action of this class of antibiotics. Furthermore, 
it leads us to hypothesize that these resistant 
bacteria probably have special membrane 
properties that interfere with the antibiotic 
action. It will be interesting to test the charge 
on the surface of these microbes and 
investigate the ability of positively charged 
antibiotics to bind to these membranes. 
The crude Chloroform extract, in our 
report of S. inconstans showed moderate 
activity against MRSA compared to purified 
extract. Isnansetyo et al. (2009) reported the 
MeOH extract of Geodia sp. exhibited potent 
antibacterial activity against oxy-tetracycline 
resistant V. harveyi with MIC 31.25 µg mL-1. 
The extract showed bacteriostatic activity at 
low concentration and bactericidal activity at 
the concentration of 4XMIC. This extract 
might be applied to control the disease caused 
by the bacterium as the extract did not show 
any toxic effect up to 125 µg mL-1 (4XMIC). 





A single well defined band showing the 
molecular weight of 3,000 Da was obtained 
using the fractions of 4 and 79 of marine 
sponge mainly by chloroform extract in our 
research. Boobathy et al. (2009) obtained the 
crude protein content of 1.62 mg/mL in 
methanolic crude extract and 1.43 mg/mL in 
the aqueous extract of marine sponge 
Callyspongia diffusa. The SDS-PAGE on gel, 
crude protein toxins yielded 6 bands in the 
chloroform extract and 5 bands in the aqueous 
extract of S. fibulatus, ranging from 14.4 to 
116 kDa molecular weight with 5 well-
defined bands of 28.5, 35.4, 45.0, 59.5, 72.3 
kDa in both the extracts. The presence of 3 
protein bands viz, 19.5, 39.0 and 66.2 kDa 
were already reported in C. diffusa. 
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